“The original-generic competition in the U.S. is our future”

“The competition between original drugs and generics in the U.S. drug market is one of the import issues the Korean pharmaceutical industry must pay attention.”

Marketing Director Ki-Hyun Ko(former pharmacist) at Inist Biopharma mentioned above about ‘DRUG WARS’ that was recently translated and published.

DRUG WARS, a book by two law professors, Evan Frondorf and Robin Feldman, is a guidance ...